(Q28273500)

5

0 references

author name string

Dieter H Meier

2

0 references

Birgit O Mikkelsen

3

0 references

John S Villumsen

Meta-analysis: pharmacologic treatment of obesity

4

0 references

language of work or name

English

0 references

publication date

June 2008

0 references

published in

Obesity

0 references

volume

16

0 references

issue

6

0 references

page(s)

1363-9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Prevalence of obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Prevalence and socioeconomic risk factors of obesity among urban female students in Al-Khobar city, Eastern Saudi Arabia, 2003.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Association between restless legs syndrome and essential tremor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Elevated body mass index is associated with executive dysfunction in otherwise healthy adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Compulsive eating and weight gain related to dopamine agonist use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Thermogenic effects of sibutramine in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56

Thermogenic drugs as a strategy for treatment of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.56